Appili Therapeutics Inc
TSX:APLI
Appili Therapeutics Inc
TSX:APLI
Price:
0.02
CAD
33.33%
Market Closed
Market Cap:
CA$2.6m
Add Note
Add Target
Capture your thoughts and set a target
Decide at what price you'd be comfortable buying and we'll help you stay ready.
Based on
Margin of Safety
0%
10%
20%
30%
40%
50%
Your Price Target
Linked to
current price
· In Buy Zone
Loading
Note attached
Choose the stock you wish to monitor with a price target
Recently Viewed
|
Appili Therapeutics Inc
TSX:APLI
|
CA |
|
Graphano Energy Ltd
XTSX:GEL
|
CA |
Balance Sheet
Balance Sheet Decomposition
Appili Therapeutics Inc
Appili Therapeutics Inc
Balance Sheet Decomposition is not available for
Appili Therapeutics Inc
Appili Therapeutics Inc
Balance Sheet
Appili Therapeutics Inc
Appili Therapeutics Inc
Currency: CAD
| Mar-2017 | Mar-2018 | Mar-2019 | Mar-2020 | Mar-2021 | Mar-2022 | Mar-2023 | Mar-2024 | Mar-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||
| Cash & Cash Equivalents |
1
|
6
|
5
|
11
|
11
|
7
|
2
|
0
|
1
|
|
| Cash |
1
|
6
|
5
|
11
|
11
|
7
|
2
|
0
|
1
|
|
| Short-Term Investments |
0
|
0
|
0
|
0
|
5
|
0
|
0
|
0
|
0
|
|
| Total Receivables |
1
|
1
|
1
|
0
|
2
|
1
|
0
|
1
|
2
|
|
| Accounts Receivables |
0
|
1
|
0
|
0
|
0
|
0
|
0
|
1
|
2
|
|
| Other Receivables |
1
|
0
|
0
|
0
|
1
|
1
|
0
|
0
|
0
|
|
| Inventory |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Other Current Assets |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Assets |
3
|
7
|
7
|
11
|
18
|
8
|
3
|
1
|
3
|
|
| PP&E Net |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| PP&E Gross |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Accumulated Depreciation |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Assets |
3
N/A
|
7
+180%
|
7
-5%
|
11
+63%
|
18
+64%
|
8
-55%
|
3
-62%
|
1
-52%
|
3
+103%
|
|
| Liabilities | ||||||||||
| Accounts Payable |
1
|
1
|
1
|
1
|
5
|
6
|
3
|
4
|
4
|
|
| Short-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Current Portion of Long-Term Debt |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
7
|
12
|
|
| Other Current Liabilities |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Total Current Liabilities |
1
|
1
|
1
|
1
|
5
|
7
|
3
|
12
|
16
|
|
| Long-Term Debt |
0
|
1
|
1
|
1
|
1
|
5
|
8
|
1
|
1
|
|
| Total Liabilities |
1
N/A
|
2
+95%
|
2
+4%
|
2
-4%
|
6
+139%
|
12
+108%
|
11
-9%
|
12
+18%
|
16
+32%
|
|
| Equity | ||||||||||
| Common Stock |
4
|
11
|
11
|
21
|
35
|
40
|
42
|
42
|
42
|
|
| Retained Earnings |
3
|
7
|
8
|
14
|
25
|
48
|
56
|
66
|
71
|
|
| Additional Paid In Capital |
0
|
1
|
1
|
2
|
3
|
5
|
6
|
13
|
15
|
|
| Total Equity |
1
N/A
|
5
+255%
|
4
-9%
|
9
+100%
|
13
+44%
|
3
N/A
|
7
-126%
|
11
-48%
|
13
-23%
|
|
| Total Liabilities & Equity |
3
N/A
|
7
+180%
|
7
-5%
|
11
+63%
|
18
+64%
|
8
-55%
|
3
-62%
|
1
-52%
|
3
+103%
|
|
| Shares Outstanding | ||||||||||
| Common Shares Outstanding |
34
|
34
|
34
|
62
|
63
|
71
|
121
|
121
|
121
|
|
Switch to:
Switch to:
See Also
Discover More
